Operating Cash Flow per Share: A measure of financial performance calculated as operating cash flow, expressed on a per share basis. Calculated as: Cash Flow from Operations / Weighted Average Shares Outstanding (Diluted)
CERo Therapeutics Holdings, Inc. (CERO) had Operating Cash Flow per Share of $-1.30 for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
-- |
|
$-5.45M |
|
-- |
|
-- |
|
$4.95M |
|
$-4.95M |
|
$-0.16M |
|
$-5.11M |
|
$-5.11M |
|
$-5.11M |
|
$-5.11M |
|
$-5.11M |
|
$-5.11M |
|
$-4.95M |
|
$-4.68M |
|
3.43M |
|
3.43M |
|
$-1.59 |
|
$-1.59 |
|
| Balance Sheet Financials | |
$5.77M |
|
$0.45M |
|
$2.22M |
|
$7.99M |
|
$7.86M |
|
-- |
|
$0.46M |
|
$8.32M |
|
$-2.76M |
|
$-0.33M |
|
$-0.33M |
|
5.17M |
|
| Cash Flow Statement Financials | |
$-4.45M |
|
-- |
|
$6.32M |
|
$3.33M |
|
$5.20M |
|
$1.88M |
|
$0.46M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.73 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-4.45M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
185.20% |
|
1550.14% |
|
-63.89% |
|
1550.14% |
|
$-0.06 |
|
$-1.30 |
|
|
Operating Cash Flow per Share |
$-1.30 |